Purpose: Uveitis is a common, sight-threatening inflammatory ocular disease and includes
multiple heterogeneous clinical entities. The prevalence of various types of uveitis depends …

Purpose To evaluate features and outcomes of eyes with retinal vasculitis and intraocular
inflammation (IOI) after intravitreal injection (IVI) of brolucizumab 6 mg/0.05 ml for treatment …

Numerous complications following COVID-19 vaccination has been reported in the
literature, with an increasing body of evidence reporting vaccination-associated uveitis …

Purpose: To describe the demographic and clinical profiles of uveitis patients seen at
secondary and tertiary care centers in Turkey. Methods: A nationwide web-based registry of …

Abstract Interleukin-6 (IL-6) is one of the key regulators behind the inflammatory and
pathological process associated with ophthalmic diseases. The role of IL-6-174 G/C …

Purpose: To compare the efficacy and safety of infliximab and interferon in patients with
refractory Behçet uveitis. Methods: Medical records of 20 patients treated with infliximab …

Introduction The search for biomarkers in juvenile idiopathic arthritis (JIA) is a promising and
rapidly expanding field of investigation. The biomarkers identified so far may help to dissect …

Human uveitis is an autoimmune disease of the central nervous system that is characterized
by ocular inflammation with the involvement of uveitogenic Th1 and Th17 responses. In …

Acthar® Gel (repository corticotropin injection [RCI]) is a naturally sourced complex mixture
of adrenocorticotropic hormone analogs and other pituitary peptides used to treat patients …

Purpose Tofacitinib is a pan-Janus kinase (JAK) inhibitor that suppresses cytokine signaling
and in turn, the cells that participate in inflammatory immunopathogenic processes. We …